A Study to Test Different Doses of BI 765049 Alone and in Combination With Ezabenlimab in Asian People With Advanced Cancer (Solid Tumours) Positive for B7-H6
Boehringer Ingelheim
Boehringer Ingelheim
7 Hills Pharma, LLC
Exscientia AI Limited
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Aptamer Sciences, Inc.
M.D. Anderson Cancer Center
University of California, Irvine
Duke University
Essen Biotech
Essen Biotech
New Phase Ltd.
Nanjing Sanhome Pharmaceutical, Co., Ltd.
DualityBio Inc.
Grey Wolf Therapeutics
Takeda
Second Life Therapeutics
RenJi Hospital
University Health Network, Toronto
Liaoning Medical Diagnosis and Treatment Technology Research and Development Co., Ltd.
Coherus Oncology, Inc.
Turning Point Therapeutics, Inc.
National Institutes of Health Clinical Center (CC)
Washington University School of Medicine
Milton S. Hershey Medical Center
Novita Pharmaceuticals, Inc.
University of California, Irvine
ModeX Therapeutics, An OPKO Health Company
Celldex Therapeutics
Columbia University
Tvardi Therapeutics, Incorporated
Intensity Therapeutics, Inc.
Centre Georges Francois Leclerc
Alliance for Clinical Trials in Oncology
Shanghai Weihe Medical Laboratory Co., Ltd.
Changhai Hospital
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
VA Office of Research and Development
University of Chicago
NantBioScience, Inc.
Xencor, Inc.
Second Affiliated Hospital of Guangzhou Medical University
Pfizer
Second Affiliated Hospital of Guangzhou Medical University
Second Affiliated Hospital of Guangzhou Medical University
Second Affiliated Hospital of Guangzhou Medical University
Washington University School of Medicine
Comprehensive Support Project for Oncology Research
Pfizer
Celldex Therapeutics
Zhejiang University